Step 1: Development

  • The Standards Development Committee drafts proposed standards.

  • Draft circulates among the Standards Development Committee for feedback and revisions.

  • This iterative process is repeated as many times as needed to achieve consensus.

Step 2: Council Review

  • The proposed standards are then circulated to a larger group of industry stakeholders called the Stakeholder Review Council for feedback.
  • Committee reviews feedback, and edits and recirculates the draft if needed.
  • When the initial draft is complete, Committee members vote to approve the proposed standards.

Step 3: Public Review

  • The Committee-approved standards undergo a defined public review period where members of the public are able to provide feedback.
  • Public comments are considered and responded to, with every effort made to ensure relevant objections and comments are addressed appropriately.
  • If a revision is needed, the draft goes back to the Committee (Step 1).
  • If revisions are not needed and there are no deliberations or appeals, NICA Board reviews documentation for procedural compliance.

Step 4: ANSI Submission

  • Following NICA Board approval, the proposed standards—along with meticulous documentation of every vote, comment, objection, and so forth—are sent to the ANSI Executive Standards Council.

Step 5: ANSI Approval

  • ANSI reviews all of the documentation to ensure procedural requirements are met.
  • The standards are approved as American National Standards.

Standards Development Committee

In order to ensure a balanced representation of stakeholders, applicants were divided into “interest categories” based on the nature of their classes of trade and/or relationship to the infusion industry.

NICA took extra steps to ensure a balance of not just interest categories, but also specialties and professions.

NICA took extra steps to ensure a balance of not just interest categories, but also specialties and professions.

STANDARDS DEVELOPMENT COMMITTEE

STAKEHOLDER REVIEW COUNCIL

Official Consensus Body; Drafts and Approves Standards
Rating Group; Reviews Draft Standards and Provides Feedback
Voting Members
Non-Voting Members
Members Appointed by the Board of Directors
Stakeholders with Direct/Material Interest; Possess Relevant Professional Experience
Knowledgable About the Subject Matter; Directly Impacted by the Standard(s)
12-18 Members
15+ Members
Single 'Interest Group" May Not Contribute to More than 1/3 of Membership
No Limitations on Size or Composition for the Stakeholder Review Council

2022-2023 Standards Development Committee Members

Editor-in-Chief

Kaitey Morgan, BSN, RN, CRNI
Chief Clinical Officer, National Infusion Center Association (NICA)
NICA Organizational Representative

 

Co-Chairs

Edie Gigot. MSN, RN, MBA
Chief Operating Officer, AdvisorWoRx

Lindsey Savickas, BSN, RN
Chief Operating Officer, Infusion Associates

STANDARDS DEVELOPMENT MEMBERS

• Andrew Donovan, BSN, RN, CIC
Lead, Infection Preventionist, Acute/ Ambulatory Care
St. Joseph Hospital/Covenant Health System

• Robert A. Dracker, MD, MHA, MBA, CPI
Medical Director
Infusacare Medical Services, PC

• Lauren Dunlap, PACS
Executive Director, Advocacy & Awareness
Immune Disorders Association (AAIDA)

• Nancy JH Ellis, MBA, MHA
Practice Administrator
Piedmont Arthritis Clinic PA

American Gastroenterological Association Organizational Representative:
• Joseph D. Feuerstein, MD
Gastroenterology Attending Physician, Center for Inflammatory Bowel Disease at Beth Israel Deaconess Medical Center
Associate Professor of Medicine Harvard Medical School

American Academy of Neurology Organizational Representative:
• Kavita Nair, MD, FAAN
Professor of Neurology
University of Colorado

• Marissa Shackleton
Executive Director
The Elliot Lewis Center

• E. Berkely Taylor-Allen, BSN, RN
Senior Regional Operations Director
Ol Infusion

American College of Rheumatology Organizational Representative:
• Kent Kwas Huston, MD
Rheumatologist
Kansas City Physician Partners

• Elizabeth Johnson LPN, CPC, PACS, BCPA
Chief Executive Officer
MedicoCX

• Kelly Kain PharmD, MBA
Founder, Chief Operating Officer
LivWell Infusions

• Michelle Levins, MSN, NP
Infusion Director
Blum Center for Health
Nurse Practitioner Specialty Infusion Centers

• McLean Mason, MBA, MHA
Senior Manager, Operations
Option Care Health

• Callie Turk, RN, MBA
Chief Operating Officer
Flexcare Infusion Centers

• Cora Vizcarra MBA, RN, CRNI, VA-BC
Infusion Therapy & Vascular Access
Consultant/Educator
IVSYNTRIX

 



STAKEHOLDER REVIEW COUNCIL

Georgia Bonney, CMPM, CRMS, CRHC
Allison Braden, PharmD
Lisa Bruce, RN, CRNI
Jason (Jake) Deutsch
Jody Huss, ACNP
Rebekkah Jackman, NP
Brittany MacQuarrie, RN
Ann Marslett MA, CMPE
Monica Parsons RN, BSN

Parul Patel
Shannon Petteruti, NP
Scott Philbrick
Aaron Primm
Erica Smith MSN, RN, IgCN
Andre Smith, BSBA, CRHC, CPB
Daniel Sweatman MBA
Bonnie Tann RN, BSN, MBA-HCA, EML. IgCN
Tara Wright RN, BSN, AVA-BC